JP2011512349A - 経口放出制御錠剤 - Google Patents

経口放出制御錠剤 Download PDF

Info

Publication number
JP2011512349A
JP2011512349A JP2010546446A JP2010546446A JP2011512349A JP 2011512349 A JP2011512349 A JP 2011512349A JP 2010546446 A JP2010546446 A JP 2010546446A JP 2010546446 A JP2010546446 A JP 2010546446A JP 2011512349 A JP2011512349 A JP 2011512349A
Authority
JP
Japan
Prior art keywords
layer
coating
alcohol
release
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010546446A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011512349A5 (enExample
Inventor
ニィティン、バラチャンドラ、ダルマディカリ
ヤショラジ、ルプシン、ザラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharma Advanced Research Co Ltd
Original Assignee
Sun Pharma Advanced Research Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharma Advanced Research Co Ltd filed Critical Sun Pharma Advanced Research Co Ltd
Publication of JP2011512349A publication Critical patent/JP2011512349A/ja
Publication of JP2011512349A5 publication Critical patent/JP2011512349A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
JP2010546446A 2008-02-15 2009-02-16 経口放出制御錠剤 Pending JP2011512349A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN339MU2008 2008-02-15
PCT/IN2009/000106 WO2009122431A2 (en) 2008-02-15 2009-02-16 Oral controlled release tablet

Publications (2)

Publication Number Publication Date
JP2011512349A true JP2011512349A (ja) 2011-04-21
JP2011512349A5 JP2011512349A5 (enExample) 2012-04-05

Family

ID=40955347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010546446A Pending JP2011512349A (ja) 2008-02-15 2009-02-16 経口放出制御錠剤

Country Status (10)

Country Link
US (1) US20090208572A1 (enExample)
EP (1) EP2242485A4 (enExample)
JP (1) JP2011512349A (enExample)
KR (1) KR20100136967A (enExample)
CN (1) CN102026628A (enExample)
BR (1) BRPI0908114A2 (enExample)
CA (1) CA2715584A1 (enExample)
MX (1) MX2010008861A (enExample)
WO (1) WO2009122431A2 (enExample)
ZA (1) ZA201006793B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016516694A (ja) * 2013-03-14 2016-06-09 フオレスト・トサラ・リミテツド オピオイド受容体モジュレーターの投与製剤
JP2022513243A (ja) * 2018-12-14 2022-02-07 ディピエッレ ファルマ ソシエタ ペル アチオニ 胃腸管におけるクロノトロピック投与のための複合モノリシックマトリックスを含む固体経口医薬組成物
JP2023525026A (ja) * 2020-05-08 2023-06-14 ヤンセン ファーマシューティカ エヌ．ベー． 酢酸アビラテロン及びニラパリブの医薬製剤

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103540568A (zh) * 2002-04-26 2014-01-29 米迪缪尼有限公司 制备流感病毒的多质粒系统
US7465456B2 (en) * 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
TWI331803B (en) 2002-08-19 2010-10-11 Univ Columbia A single-shot semiconductor processing system and method having various irradiation patterns
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
WO2005062820A2 (en) * 2003-12-23 2005-07-14 Medimmune Vaccines, Inc Multi plasmid system for the production of influenza virus
CA2690196A1 (en) * 2007-06-18 2008-12-24 Medimmune, Llc Influenza b viruses having alterations in the hemaglutinin polypeptide
WO2010139111A1 (en) 2009-06-02 2010-12-09 Dow Global Technologies Inc. Sustained release dosage form
US20120207825A1 (en) * 2009-09-17 2012-08-16 Sunilendu Bhushan Roy Pharmaceutical compositions for reducing alcohol-induced dose dumping
US8901113B2 (en) * 2009-09-30 2014-12-02 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
EP2714015B1 (en) * 2011-06-01 2017-03-15 FMC Corporation Controlled release solid dose forms
ES2691982T3 (es) 2012-11-30 2018-11-29 Acura Pharmaceuticals, Inc. Liberación autorregulada de un principio activo farmacéutico
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
EA030138B1 (ru) * 2016-06-15 2018-06-29 Общество С Ограниченной Ответственностью "Фармадиол" Фармацевтические композиции, включающие антикоагулянт n-(5-хлорпиридин-2-ил)-2-({4-[этанимидоил(метил)амино]бензоил}амино)-5-метилбензамид
WO2025137498A1 (en) * 2023-12-20 2025-06-26 Areteia Therapeutics, Inc. Matrix tablets of dexpramipexole and methods of manufacturing and use thereof
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006123364A2 (en) * 2005-03-14 2006-11-23 Sun Pharmaceutical Industries Limited Oral drug delivery system providing a coating comprising both a cellulose and a methacrylic acid derivative
JP2007505894A (ja) * 2003-09-19 2007-03-15 サン・ファーマシューティカル・インダストリーズ・リミテッド 経口薬送達システム
WO2007053698A2 (en) * 2005-10-31 2007-05-10 Alza Corporation Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4693896A (en) * 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
WO1993006821A1 (fr) * 1991-10-04 1993-04-15 Yoshitomi Pharmaceutical Industries, Ltd. Comprime a liberation prolongee
EP0621032B1 (en) * 1993-04-23 2000-08-09 Novartis AG Controlled release drug delivery device
RU2134103C1 (ru) * 1993-05-15 1999-08-10 Берингер Маннхайм ГмбХ Таблетка с улучшенной биодоступностью биологически активного вещества и вещество, повышающее биодоступность
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
JP5170723B2 (ja) * 1997-01-10 2013-03-27 アボット・ラボラトリーズ 活性薬剤の制御放出用錠剤
US6322819B1 (en) * 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
EP1967185A1 (en) * 1999-12-23 2008-09-10 Pfizer Products Inc. Hydrogel-driven drug dosage form
US6720005B1 (en) * 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
JP4426286B2 (ja) * 2001-07-10 2010-03-03 テバ ファーマシューティカル インダストリーズ リミティド ０次、０次−二相性、上昇型又は下降型薬物放出のための薬物送達システム
GB0117618D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
ITMI20020515A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
ITMI20020514A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20060193911A1 (en) * 2005-02-28 2006-08-31 Penwest Pharmaceuticals Co., Controlled release venlafaxine formulations
EP1895989A2 (en) * 2005-06-03 2008-03-12 Egalet A/S A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids
WO2007057762A2 (en) * 2005-11-16 2007-05-24 Pfizer Limited Osmotic bi-layer tablet
US20070264346A1 (en) * 2006-02-16 2007-11-15 Flamel Technologies Multimicroparticulate pharmaceutical forms for oral administration

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505894A (ja) * 2003-09-19 2007-03-15 サン・ファーマシューティカル・インダストリーズ・リミテッド 経口薬送達システム
WO2006123364A2 (en) * 2005-03-14 2006-11-23 Sun Pharmaceutical Industries Limited Oral drug delivery system providing a coating comprising both a cellulose and a methacrylic acid derivative
WO2007053698A2 (en) * 2005-10-31 2007-05-10 Alza Corporation Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016516694A (ja) * 2013-03-14 2016-06-09 フオレスト・トサラ・リミテツド オピオイド受容体モジュレーターの投与製剤
JP2019014744A (ja) * 2013-03-14 2019-01-31 フオレスト・トサラ・リミテツド オピオイド受容体モジュレーターの投与製剤
JP2022513243A (ja) * 2018-12-14 2022-02-07 ディピエッレ ファルマ ソシエタ ペル アチオニ 胃腸管におけるクロノトロピック投与のための複合モノリシックマトリックスを含む固体経口医薬組成物
JP2023525026A (ja) * 2020-05-08 2023-06-14 ヤンセン ファーマシューティカ エヌ．ベー． 酢酸アビラテロン及びニラパリブの医薬製剤

Also Published As

Publication number Publication date
BRPI0908114A2 (pt) 2015-10-06
WO2009122431A2 (en) 2009-10-08
KR20100136967A (ko) 2010-12-29
CA2715584A1 (en) 2009-10-08
EP2242485A2 (en) 2010-10-27
CN102026628A (zh) 2011-04-20
US20090208572A1 (en) 2009-08-20
MX2010008861A (es) 2011-02-22
ZA201006793B (en) 2011-05-25
WO2009122431A3 (en) 2010-01-07
EP2242485A4 (en) 2013-05-08

Similar Documents

Publication Publication Date Title
JP2011512349A (ja) 経口放出制御錠剤
US8470367B2 (en) Oral drug delivery system
US8535717B2 (en) Pharmaceutical composition
US8187633B2 (en) Controlled release coated tablets having prolonged gastric retention
US10226428B2 (en) Oral drug delivery system
JP5826456B2 (ja) コーティングされていない分離したユニットおよび延長放出マトリクスを含む制御放出配合物
US10213387B2 (en) Oral drug delivery system
WO2009087663A2 (en) Oral controlled release coated tablet
US20080206338A1 (en) Controlled release formulations of an alpha-adrenergic receptor antagonist
WO2017037742A1 (en) Oral pharmaceutical composition of tizandine
MXPA06002994A (en) Oral drug delivery system
HK1092718A (en) Oral drug delivery system

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120214

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120214

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130830

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130906

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140307